Patents Assigned to Pharmaquest Limited
  • Method of treating depression using 1-threo-methylphenidate
    Patent number: 6395752
    Abstract: A method of treating dysphoria or depression is disclosed in a patient which comprises the step of administering orally or non-orally to said patient, a therapeutically effective amount of 1-threo-methylphenidate or a pharmaceutically acceptable acid addition salt thereof.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: May 28, 2002
    Assignee: Pharmaquest Limited
    Inventors: Kamal K. Midha, Martin Teicher, Vijai Kumar
  • Method of treating depression using l-threo-methylphenidate
    Patent number: 6127385
    Abstract: A method of treating depression to elicit prompt relief from depression is disclosed. The method comprises the step of administering orally or non-orally to said patient, a therapeutically effective amount of l-threo-methylphenidate or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: October 3, 2000
    Assignee: Pharmaquest Limited
    Inventors: Kamal K. Midha, Martin Teicher, Vijai Kumar